View ValuationRianlon 将来の成長Future 基準チェック /16Rianlon利益と収益がそれぞれ年間18.2%と13%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に12% 18.3%なると予測されています。主要情報18.2%収益成長率18.26%EPS成長率Chemicals 収益成長29.6%収益成長率13.0%将来の株主資本利益率11.98%アナリストカバレッジLow最終更新日06 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 28Rianlon Corporation, Annual General Meeting, May 25, 2026Rianlon Corporation, Annual General Meeting, May 25, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tianjin Chinaお知らせ • Mar 31Rianlon Corporation to Report Q1, 2026 Results on Apr 28, 2026Rianlon Corporation announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 31Rianlon Corporation to Report Fiscal Year 2025 Results on Apr 28, 2026Rianlon Corporation announced that they will report fiscal year 2025 results on Apr 28, 2026お知らせ • Sep 30Rianlon Corporation to Report Q3, 2025 Results on Oct 21, 2025Rianlon Corporation announced that they will report Q3, 2025 results on Oct 21, 2025お知らせ • Jul 02Rianlon Corporation to Report First Half, 2025 Results on Aug 28, 2025Rianlon Corporation announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • May 22Rianlon Corporation Approves Dividend for 2024Rianlon Corporation its Annual General Meeting of 2024 on 16 May 2025, during which the following proposal(s) was/were approved: Cash dividend per 10 shares (tax included): CNY 3.70000000.お知らせ • Apr 23Rianlon Corporation Proposes Final Cash Dividend for 2024Rianlon Corporation proposed final cash dividend of CNY 3.70000000 per 10 shares (tax included) for 2024.お知らせ • Apr 22Rianlon Corporation, Annual General Meeting, May 16, 2025Rianlon Corporation, Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin Chinaお知らせ • Mar 31Rianlon Corporation to Report Q1, 2025 Results on Apr 29, 2025Rianlon Corporation announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 31Rianlon Corporation to Report Fiscal Year 2024 Results on Apr 22, 2025Rianlon Corporation announced that they will report fiscal year 2024 results on Apr 22, 2025Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.44 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.41 (down from CN¥0.44 in 3Q 2023). Revenue: CN¥1.45b (up 6.9% from 3Q 2023). Net income: CN¥93.8m (down 6.5% from 3Q 2023). Profit margin: 6.5% (down from 7.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 9% per year.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥28.12, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.お知らせ • Sep 30Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024Rianlon Corporation announced that they will report Q3, 2024 results on Oct 29, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥26.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.49 (vs CN¥0.43 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.43 in 2Q 2023). Revenue: CN¥1.47b (up 11% from 2Q 2023). Net income: CN¥113.0m (up 13% from 2Q 2023). Profit margin: 7.7% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.お知らせ • Jun 29Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024Rianlon Corporation announced that they will report first half, 2024 results on Aug 26, 2024Declared Dividend • Jun 27Dividend of CN¥0.34 announcedDividend of CN¥0.34 is the same as last year. Ex-date: 2nd July 2024 Payment date: 2nd July 2024 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 26Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024Rianlon Corporation announced final cash dividend of CNY 3.44000000 per 10 A shares for 2023. Record date: 01 July 2024. Ex-date: 02 July 2024. Payment date: 02 July 2024.New Risk • Apr 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (11% average weekly change).Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥27.51, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years.お知らせ • Apr 19Rianlon Corporation, Annual General Meeting, May 13, 2024Rianlon Corporation, Annual General Meeting, May 13, 2024, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin ChinaReported Earnings • Apr 18Full year 2023 earnings released: EPS: CN¥1.58 (vs CN¥2.40 in FY 2022)Full year 2023 results: EPS: CN¥1.58 (down from CN¥2.40 in FY 2022). Revenue: CN¥5.28b (up 9.0% from FY 2022). Net income: CN¥362.5m (down 31% from FY 2022). Profit margin: 6.9% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Mar 30Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024Rianlon Corporation announced that they will report Q1, 2024 results on Apr 27, 2024New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin).Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥20.32, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.お知らせ • Dec 29Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024Rianlon Corporation announced that they will report fiscal year 2023 results on Apr 18, 2024Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.44 (down from CN¥0.70 in 3Q 2022). Revenue: CN¥1.35b (up 1.9% from 3Q 2022). Net income: CN¥100.3m (down 38% from 3Q 2022). Profit margin: 7.4% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • Sep 30Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023Rianlon Corporation announced that they will report Q3, 2023 results on Oct 24, 2023Board Change • Sep 28Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Non-Independent Director Borui Han was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.70 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.43 (down from CN¥0.70 in 2Q 2022). Revenue: CN¥1.32b (up 5.0% from 2Q 2022). Net income: CN¥99.7m (down 33% from 2Q 2022). Profit margin: 7.6% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Jul 01Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023Rianlon Corporation announced that they will report first half, 2023 results on Aug 25, 2023お知らせ • Jun 15Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023Rianlon Corporation announced final cash dividend of CNY 3.44 per 10 shares on A shares for the year 2022. Record date is June 20, 2023, Ex-Date is June 21, 2023 and Payment Date is June 21, 2023.Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥2.40 (vs CN¥2.04 in FY 2021)Full year 2022 results: EPS: CN¥2.40 (up from CN¥2.04 in FY 2021). Revenue: CN¥4.84b (up 41% from FY 2021). Net income: CN¥525.7m (up 26% from FY 2021). Profit margin: 11% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.55 in 3Q 2021). Revenue: CN¥1.33b (up 46% from 3Q 2021). Net income: CN¥160.7m (up 42% from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.47 in 2Q 2021). Revenue: CN¥1.26b (up 58% from 2Q 2021). Net income: CN¥148.1m (up 54% from 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 26%, compared to a 42% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • May 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥45.88, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.Reported Earnings • Apr 28First quarter 2022 earnings released: EPS: CN¥0.62 (vs CN¥0.44 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.62 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥1.01b (up 23% from 1Q 2021). Net income: CN¥126.2m (up 40% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Wei Man Hou was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.43 in FY 2020). Revenue: CN¥3.44b (up 39% from FY 2020). Net income: CN¥417.6m (up 43% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue exceeded analyst estimates by 7.8%. Over the next year, revenue is forecast to grow 19%, compared to a 47% growth forecast for the industry in China.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥908.7m (up 52% from 3Q 2020). Net income: CN¥113.4m (up 45% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.01, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 14% over the past year.Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥795.3m (up 38% from 2Q 2020). Net income: CN¥95.9m (up 34% from 2Q 2020). Profit margin: 12% (in line with 2Q 2020).Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥821.4m (up 46% from 1Q 2020). Net income: CN¥90.4m (up 43% from 1Q 2020). Profit margin: 11% (in line with 1Q 2020).Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.21, the stock trades at a trailing P/E ratio of 28.1x, up from the previous P/E ratio of 23.9x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.Reported Earnings • Mar 09Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥2.48b (up 26% from FY 2019). Net income: CN¥293.0m (up 12% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Mar 09Revenue beats expectationsRevenue exceeded analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.Is New 90 Day High Low • Jan 31New 90-day low: CN¥34.20The company is down 6.0% from its price of CN¥36.39 on 03 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥6.01 per share.Is New 90 Day High Low • Dec 04New 90-day high: CN¥44.00The company is up 25% from its price of CN¥35.07 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.63 per share.Is New 90 Day High Low • Nov 14New 90-day high: CN¥39.29The company is up 7.0% from its price of CN¥36.84 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.82 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥256.7m, down 2.7% from the prior year. Total revenue was CN¥2.28b over the last 12 months, up 27% from the prior year.業績と収益の成長予測XSEC:300596 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20288,925877N/A1,435312/31/20278,004748N/A1,296512/31/20266,978633N/A1,329412/31/20256,023497136378N/A9/30/20255,931505206458N/A6/30/20255,86244798286N/A3/31/20255,814427116350N/A12/31/20245,687426209464N/A9/30/20245,686393-22348N/A6/30/20245,593400-239249N/A3/31/20245,447387-293256N/A12/31/20235,278362-401173N/A9/30/20235,106374-203292N/A6/30/20235,08143446426N/A3/31/20235,01848287369N/A1/1/20234,843526221514N/A9/30/20224,514553190498N/A6/30/20224,096506-57414N/A3/31/20223,634453-201304N/A12/31/20213,445418-203312N/A9/30/20213,270379-201271N/A6/30/20212,960344-232141N/A3/31/20212,741320-160220N/A12/31/20202,483293-146187N/A9/30/20202,282257-146248N/A6/30/20202,253272-79308N/A3/31/20202,132272-170197N/A12/31/20191,978262-230166N/A9/30/20191,792264N/A-51N/A6/30/20191,640232N/A-43N/A3/31/20191,574211N/A57N/A12/31/20181,488193N/A35N/A9/30/20181,401185N/A75N/A6/30/20181,295159N/A58N/A3/31/20181,181136N/A-19N/A12/31/20171,142131N/A31N/A9/30/20171,089111N/A43N/A6/30/201798999N/A0N/A3/31/201789996N/A29N/A12/31/201680891N/A24N/A9/30/201671990N/A15N/A12/31/201560574N/A81N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 300596の予測収益成長率 (年間18.2% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 300596の収益 ( 18.2% ) CN市場 ( 26.8% ) よりも低い成長が予測されています。高成長収益: 300596の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 300596の収益 ( 13% ) CN市場 ( 15.9% ) よりも低い成長が予測されています。高い収益成長: 300596の収益 ( 13% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 300596の 自己資本利益率 は、3年後には低くなると予測されています ( 12 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/15 13:49終値2026/05/15 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Rianlon Corporation 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Wang PengChina Galaxy Securities Co., Ltd.Wenpo RenChina Galaxy Securities Co., Ltd.Qidi ZhaiChina Galaxy Securities Co., Ltd.10 その他のアナリストを表示
お知らせ • Apr 28Rianlon Corporation, Annual General Meeting, May 25, 2026Rianlon Corporation, Annual General Meeting, May 25, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
お知らせ • Mar 31Rianlon Corporation to Report Q1, 2026 Results on Apr 28, 2026Rianlon Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 31Rianlon Corporation to Report Fiscal Year 2025 Results on Apr 28, 2026Rianlon Corporation announced that they will report fiscal year 2025 results on Apr 28, 2026
お知らせ • Sep 30Rianlon Corporation to Report Q3, 2025 Results on Oct 21, 2025Rianlon Corporation announced that they will report Q3, 2025 results on Oct 21, 2025
お知らせ • Jul 02Rianlon Corporation to Report First Half, 2025 Results on Aug 28, 2025Rianlon Corporation announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • May 22Rianlon Corporation Approves Dividend for 2024Rianlon Corporation its Annual General Meeting of 2024 on 16 May 2025, during which the following proposal(s) was/were approved: Cash dividend per 10 shares (tax included): CNY 3.70000000.
お知らせ • Apr 23Rianlon Corporation Proposes Final Cash Dividend for 2024Rianlon Corporation proposed final cash dividend of CNY 3.70000000 per 10 shares (tax included) for 2024.
お知らせ • Apr 22Rianlon Corporation, Annual General Meeting, May 16, 2025Rianlon Corporation, Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
お知らせ • Mar 31Rianlon Corporation to Report Q1, 2025 Results on Apr 29, 2025Rianlon Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 31Rianlon Corporation to Report Fiscal Year 2024 Results on Apr 22, 2025Rianlon Corporation announced that they will report fiscal year 2024 results on Apr 22, 2025
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.44 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.41 (down from CN¥0.44 in 3Q 2023). Revenue: CN¥1.45b (up 6.9% from 3Q 2023). Net income: CN¥93.8m (down 6.5% from 3Q 2023). Profit margin: 6.5% (down from 7.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 9% per year.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥28.12, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.
お知らせ • Sep 30Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024Rianlon Corporation announced that they will report Q3, 2024 results on Oct 29, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥26.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.49 (vs CN¥0.43 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.43 in 2Q 2023). Revenue: CN¥1.47b (up 11% from 2Q 2023). Net income: CN¥113.0m (up 13% from 2Q 2023). Profit margin: 7.7% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.
お知らせ • Jun 29Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024Rianlon Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Declared Dividend • Jun 27Dividend of CN¥0.34 announcedDividend of CN¥0.34 is the same as last year. Ex-date: 2nd July 2024 Payment date: 2nd July 2024 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 26Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024Rianlon Corporation announced final cash dividend of CNY 3.44000000 per 10 A shares for 2023. Record date: 01 July 2024. Ex-date: 02 July 2024. Payment date: 02 July 2024.
New Risk • Apr 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (11% average weekly change).
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥27.51, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years.
お知らせ • Apr 19Rianlon Corporation, Annual General Meeting, May 13, 2024Rianlon Corporation, Annual General Meeting, May 13, 2024, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
Reported Earnings • Apr 18Full year 2023 earnings released: EPS: CN¥1.58 (vs CN¥2.40 in FY 2022)Full year 2023 results: EPS: CN¥1.58 (down from CN¥2.40 in FY 2022). Revenue: CN¥5.28b (up 9.0% from FY 2022). Net income: CN¥362.5m (down 31% from FY 2022). Profit margin: 6.9% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Mar 30Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024Rianlon Corporation announced that they will report Q1, 2024 results on Apr 27, 2024
New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin).
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥20.32, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
お知らせ • Dec 29Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024Rianlon Corporation announced that they will report fiscal year 2023 results on Apr 18, 2024
Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.44 (down from CN¥0.70 in 3Q 2022). Revenue: CN¥1.35b (up 1.9% from 3Q 2022). Net income: CN¥100.3m (down 38% from 3Q 2022). Profit margin: 7.4% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • Sep 30Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023Rianlon Corporation announced that they will report Q3, 2023 results on Oct 24, 2023
Board Change • Sep 28Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Non-Independent Director Borui Han was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.70 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.43 (down from CN¥0.70 in 2Q 2022). Revenue: CN¥1.32b (up 5.0% from 2Q 2022). Net income: CN¥99.7m (down 33% from 2Q 2022). Profit margin: 7.6% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Jul 01Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023Rianlon Corporation announced that they will report first half, 2023 results on Aug 25, 2023
お知らせ • Jun 15Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023Rianlon Corporation announced final cash dividend of CNY 3.44 per 10 shares on A shares for the year 2022. Record date is June 20, 2023, Ex-Date is June 21, 2023 and Payment Date is June 21, 2023.
Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥2.40 (vs CN¥2.04 in FY 2021)Full year 2022 results: EPS: CN¥2.40 (up from CN¥2.04 in FY 2021). Revenue: CN¥4.84b (up 41% from FY 2021). Net income: CN¥525.7m (up 26% from FY 2021). Profit margin: 11% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.55 in 3Q 2021). Revenue: CN¥1.33b (up 46% from 3Q 2021). Net income: CN¥160.7m (up 42% from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.47 in 2Q 2021). Revenue: CN¥1.26b (up 58% from 2Q 2021). Net income: CN¥148.1m (up 54% from 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 26%, compared to a 42% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • May 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥45.88, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.
Reported Earnings • Apr 28First quarter 2022 earnings released: EPS: CN¥0.62 (vs CN¥0.44 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.62 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥1.01b (up 23% from 1Q 2021). Net income: CN¥126.2m (up 40% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Wei Man Hou was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.43 in FY 2020). Revenue: CN¥3.44b (up 39% from FY 2020). Net income: CN¥417.6m (up 43% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue exceeded analyst estimates by 7.8%. Over the next year, revenue is forecast to grow 19%, compared to a 47% growth forecast for the industry in China.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥908.7m (up 52% from 3Q 2020). Net income: CN¥113.4m (up 45% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.01, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 14% over the past year.
Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥795.3m (up 38% from 2Q 2020). Net income: CN¥95.9m (up 34% from 2Q 2020). Profit margin: 12% (in line with 2Q 2020).
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥821.4m (up 46% from 1Q 2020). Net income: CN¥90.4m (up 43% from 1Q 2020). Profit margin: 11% (in line with 1Q 2020).
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.21, the stock trades at a trailing P/E ratio of 28.1x, up from the previous P/E ratio of 23.9x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.
Reported Earnings • Mar 09Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥2.48b (up 26% from FY 2019). Net income: CN¥293.0m (up 12% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Mar 09Revenue beats expectationsRevenue exceeded analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.
Is New 90 Day High Low • Jan 31New 90-day low: CN¥34.20The company is down 6.0% from its price of CN¥36.39 on 03 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥6.01 per share.
Is New 90 Day High Low • Dec 04New 90-day high: CN¥44.00The company is up 25% from its price of CN¥35.07 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.63 per share.
Is New 90 Day High Low • Nov 14New 90-day high: CN¥39.29The company is up 7.0% from its price of CN¥36.84 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.82 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥256.7m, down 2.7% from the prior year. Total revenue was CN¥2.28b over the last 12 months, up 27% from the prior year.